NY Fed’s Empire State index tumbles to four-month low. Manufacturing side of the economy struggling.
The numbers A survey of business conditions in the New York region sank to -14.5 in December and hit a four-month low, reflecting the
Barclays expects BoE to deliver rate cut in May 2024
(Reuters) – Barclays said on Friday it expects the Bank of England (BoE) to start its interest-rate cut of 25 basis points in May,
Auto workers’ deal boosts U.S. industrial production, but other manufacturers struggle
The numbers: Industrial production rebounded in November and rose 0.2% after a major auto strike ended, but most other manufacturers saw little improvement. Economists surveyed
Indian government says IMF debt warning a worst case scenario
NEW DELHI (Reuters) – The Indian government said on Friday a warning from the International Monetary Fund (IMF) that the country’s debt to GDP
U.S. economy posts steady but lackluster growth at year’s end, S&P finds
The numbers: The service side of the U.S. economy grew faster at the end of the year while manufacturers remained mired in a slump,
Fed rate cuts firmly in view for 2024, even as rate-setters shift
By Ann Saphir SAN FRANCISCO (Reuters) – The annual rotation on the U.S. Federal Reserve’s interest-rate-setting committee means its 2024 voting members lean slightly
Builder-confidence index rises for the first time in five months as mortgage rates fall
The numbers: Builder confidence rose in December for the first time in five months as mortgage rates fell. Builder confidence increased as rates fell
Dollar slips to 5-month low as US inflation cools
By Saqib Iqbal Ahmed NEW YORK (Reuters) -The edged down on Friday, hitting a near five-month low as data showed annual U.S. inflation slowed
U.S. housing starts surge to highest level since May
The numbers: Construction of new homes rose 14.8% in November, as builders scaled up new projects. The pace of construction increased as builders saw
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion
By Michael Erman and Manas Mishra (Reuters) -Bristol Myers Squibb on Friday agreed to buy Karuna Therapeutics (NASDAQ:) for $14 billion, gaining a promising
Most Read
